A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study

Patrick Neven, Nicole Stahl, Maria Vidal, Miguel Martín, Peter A. Kaufman, Nadia Harbeck, Kelly K. Hunt, Stacey Carter, Francois-Clement Bidard, Peter A. Fasching, Philippe Aftimos, Duncan Wheatley, Erika Hamilton, Rebecca Aft, Swati Kulkarni, Peter Schmid, Manali Bhave, Roohi Ismail-Khan, Claudia Karacsonyi, Shawn T. Estrem, Bastien Nguyen, Umut Ozbek, Eunice Yuen, Vanessa Rodrik-Outmezguine, Eva Ciruelos

Open source

DOI: 10.1158/1078-0432.ccr-24-2113
Published: 2024-10-08
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-2113,
  title = {A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study},
  author = {Patrick Neven and Nicole Stahl and Maria Vidal and Miguel Martín and Peter A. Kaufman and Nadia Harbeck and Kelly K. Hunt and Stacey Carter and Francois-Clement Bidard and Peter A. Fasching and Philippe Aftimos and Duncan Wheatley and Erika Hamilton and Rebecca Aft and Swati Kulkarni and Peter Schmid and Manali Bhave and Roohi Ismail-Khan and Claudia Karacsonyi and Shawn T. Estrem and Bastien Nguyen and Umut Ozbek and Eunice Yuen and Vanessa Rodrik-Outmezguine and Eva Ciruelos},
  year = {2024},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-2113},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-2113}
}

RIS

TY  - JOUR
TI  - A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study
AU  - Patrick Neven
AU  - Nicole Stahl
AU  - Maria Vidal
AU  - Miguel Martín
AU  - Peter A. Kaufman
AU  - Nadia Harbeck
AU  - Kelly K. Hunt
AU  - Stacey Carter
AU  - Francois-Clement Bidard
AU  - Peter A. Fasching
AU  - Philippe Aftimos
AU  - Duncan Wheatley
AU  - Erika Hamilton
AU  - Rebecca Aft
AU  - Swati Kulkarni
AU  - Peter Schmid
AU  - Manali Bhave
AU  - Roohi Ismail-Khan
AU  - Claudia Karacsonyi
AU  - Shawn T. Estrem
AU  - Bastien Nguyen
AU  - Umut Ozbek
AU  - Eunice Yuen
AU  - Vanessa Rodrik-Outmezguine
AU  - Eva Ciruelos
PY  - 2024
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-2113
UR  - https://doi.org/10.1158/1078-0432.ccr-24-2113
ER  -

APA

Neven, P., Stahl, N., Vidal, M., Martín, M., Kaufman, P. A., Harbeck, N., Hunt, K. K., Carter, S., Bidard, F., Fasching, P. A., Aftimos, P., Wheatley, D., Hamilton, E., Aft, R., Kulkarni, S., Schmid, P., Bhave, M., Ismail-Khan, R., Karacsonyi, C., Estrem, S. T., Nguyen, B., Ozbek, U., Yuen, E., Rodrik-Outmezguine, V., & Ciruelos, E. (2024). A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-2113

Source records

crossref · retrieved 2026-09-26T21:05:11.817Z